intranasal vaccine
- India
DGCI approves for phase III trial of Bharat Biotech intranasal vaccine as booster
New Delhi: The Subject Experts Committee (SEC) of the Drug Controller General of India (DGCI) on Wednesday granted “in principle” approval to Bharat Biotech to conduct “Phase III superiority study and Phase…